NCT05646134

Brief Summary

This clinical trial aims to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) on upper extremity motor function in stroke patients. The main questions it seeks to answer are:

  1. 1.Whether repetitive transcranial magnetic stimulation (rTMS) has a positive effect on upper extremity motor function in stroke patients.
  2. 2.Which stimulation protocol (low frequency - LF or high-frequency - HF) has better outcomes for improving upper extremity motor function in stroke patients? Participants will receive 10 procedures of repetitive transcranial magnetic stimulation (rTMS) over two weeks. They will be randomly assigned into low-frequency, high-frequency rTMS groups or sham stimulation groups. Upper extremity motor function will be evaluated twice: before stimulation and 3-4 weeks after stimulation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
0mo left

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

December 12, 2022

Status Verified

December 1, 2022

Enrollment Period

4.6 years

First QC Date

October 25, 2022

Last Update Submit

December 2, 2022

Conditions

Keywords

StrokeStroke rehabilitationRepetitive transcranial magnetic stimulation

Outcome Measures

Primary Outcomes (4)

  • Change of upper limb motor score in Fugl-Meyer Assessment

    Fugl-Meyer test for Upper Extremity will be performed before and one month after 10 rTMS sessions. The minimum value of the Fugl-Meyer Assessment is 0 whereas the maximum value is 66 points. The higher the score the better the motor function of the upper extremity.

    7 weeks

  • Change of Nine Hole Peg Test (9HPT) score

    Nine Hole Peg Test (9HPT) will be performed before and one month after 10 rTMS sessions for measuring finger dexterity. During 9HPT a patient takes the pegs from a container, one by one, and places them into the holes on the board, as quickly as possible, using only the hand. The faster a patient finishes the test the better finger dexterity (measured by seconds).

    7 weeks

  • Change of box and block test (BBT) score

    Box and block test (BBT) will be performed before and one month after 10 rTMS sessions for measuring unilateral gross manual dexterity. During BBT a patient moves, one by one, the maximum number of blocks from one compartment of a box to another within 60 seconds. The more blocks are moved to another compartment the better the manual dexterity of the upper extremity.

    7 weeks

  • Change of hand grip strength

    Hand grip strength will be measured in kilograms using a dynamometer before and one month after 10 rTMS sessions. The higher the score the stronger the forearm muscles.

    7 weeks

Secondary Outcomes (1)

  • Change of Functional Independence Measure (FIM) test score.

    7 weeks

Study Arms (3)

Low Frequency Experimental Group

EXPERIMENTAL

Participants in this Arm will receive 10 sessions of Low Frequency (1 Hz) rTMS Participants in this Arm will receive 10 sessions of High Frequency (10 Hz) rTMS

Device: Repetitive Transcranial Magnetic Stimulation

High Frequency Experimental Group

EXPERIMENTAL

Participants in this Arm will receive 10 sessions of High Frequency (10 Hz) rTMS

Device: Repetitive Transcranial Magnetic Stimulation

Sham Stimulation Control Group

SHAM COMPARATOR

Participants in this Arm will receive 10 sessions of Sham rTMS

Device: Sham Transcranial Magnetic Stimulation

Interventions

Repetitive transcranial magnetic stimulation (rTMS) is a form of non-invasive brain stimulation therapy that modulates brain excitability.

High Frequency Experimental GroupLow Frequency Experimental Group

During Sham Transcranial Magnetic Stimulation the coil will be facing the wall making the stimulation inactive

Sham Stimulation Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ischemic stroke of the middle cerebral artery, confirmed by instrumental tests (CT, MRI).
  • Acute hemiplegia/hemiparesis, hand motor deficit, muscle strength ≤ 4 points (as assessed by the Lovett scale).
  • No severe deficit in cognitive functions.

You may not qualify if:

  • Patients with implanted ferromagnetic or other metal devices sensitive to a magnetic field in the head or neck area; cochlear implants; implanted neurostimulators, pacemakers, or drug delivery pumps.
  • Complete aphasia or severe cognitive impairment.
  • Taking tricyclic antidepressants, neuroleptics, or benzodiazepines.
  • Previous skull fractures or other head injuries with loss of consciousness.
  • History of epilepsy or seizures.
  • Spasticity of the upper limb (Ashworth scale \>2 b.).
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lithuanian University of Health Sciences

Kaunas, 44307, Lithuania

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeStroke

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Central Study Contacts

Laura Petrusevičienė, MD

CONTACT

Raimondas Savickas, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 25, 2022

First Posted

December 12, 2022

Study Start

June 1, 2021

Primary Completion

January 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

December 12, 2022

Record last verified: 2022-12

Locations